Literature DB >> 20843413

Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings.

E Nardell1, A Dharmadhikari.   

Abstract

Ongoing transmission and re-infection, primarily in congregate settings, is a key factor fueling the global multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB) epidemic, especially in association with the human immunodeficiency virus. Even as efforts to broadly implement conventional TB transmission control measures begin, current strategies may be incompletely effective under the overcrowded conditions extant in high-burden, resource-limited settings. Longstanding evidence suggesting that TB patients on effective therapy rapidly become non-infectious and that unsuspected, untreated TB cases account for the most transmission makes a strong case for the implementation of rapid point-of-care diagnostics coupled with fully supervised effective treatment. Among the most important decisions affecting transmission, the choice of an MDR-TB treatment model that includes community-based treatment may offer important advantages over hospital or clinic-based care, not only in cost and effectiveness, but also in transmission control. In the community, too, rapid identification of infectious cases, especially drug-resistant cases, followed by effective, fully supervised treatment, is critical to stopping transmission. Among the conventional interventions available, we present a simple triage and separation strategy, point out that separation is intimately linked to the design and engineering of clinical space and call attention to the pros and cons of natural ventilation, simple mechanical ventilation systems, germicidal ultraviolet air disinfection, fit-tested respirators on health care workers and short-term use of masks on patients before treatment is initiated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843413      PMCID: PMC3709569     

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  44 in total

1.  Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience.

Authors:  Sonya Shin; Jennifer Furin; Jaime Bayona; Kedar Mate; Jim Yong Kim; Paul Farmer
Journal:  Soc Sci Med       Date:  2004-10       Impact factor: 4.634

2.  Nosocomial transmission of tuberculosis from unsuspected disease.

Authors:  H S Kantor; R Poblete; S L Pusateri
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

3.  Monitoring human exposures to upper-room germicidal ultraviolet irradiation.

Authors:  Melvin W First; Robert A Weker; Shojiro Yasui; Edward A Nardell
Journal:  J Occup Environ Hyg       Date:  2005-05       Impact factor: 2.155

4.  Regarding antileprosy vaccine--an apprehension by Dr. Prakash.

Authors:  P E Fine
Journal:  Int J Lepr Other Mycobact Dis       Date:  1996-12

5.  Acceptability of community and health facility-based directly observed treatment of tuberculosis in Tanzanian urban setting.

Authors:  Eliud Wandwalo; Emmanuel Makundi; Torunn Hasler; Odd Morkve
Journal:  Health Policy       Date:  2005-12-13       Impact factor: 2.980

6.  HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV.

Authors:  Pam Sonnenberg; Judith R Glynn; Katherine Fielding; Jill Murray; Peter Godfrey-Faussett; Stuart Shearer
Journal:  AIDS       Date:  2004-03-05       Impact factor: 4.177

7.  Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.

Authors:  Carole Mitnick; Jaime Bayona; Eda Palacios; Sonya Shin; Jennifer Furin; Felix Alcántara; Epifanio Sánchez; Madeleny Sarria; Mercedes Becerra; Mary C Smith Fawzi; Saidi Kapiga; Donna Neuberg; James H Maguire; Jim Yong Kim; Paul Farmer
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

Review 8.  Vaccines, genes and trials.

Authors:  P E Fine
Journal:  Novartis Found Symp       Date:  1998

9.  Natural ventilation for the prevention of airborne contagion.

Authors:  A Roderick Escombe; Clarissa C Oeser; Robert H Gilman; Marcos Navincopa; Eduardo Ticona; William Pan; Carlos Martínez; Jesus Chacaltana; Richard Rodríguez; David A J Moore; Jon S Friedland; Carlton A Evans
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

10.  Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa.

Authors:  Kwonjune J Seung; David B Omatayo; Salmaan Keshavjee; Jennifer J Furin; Paul E Farmer; Hind Satti
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more
  35 in total

1.  Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.

Authors:  J C M Brust; N S Shah; M Scott; K Chaiyachati; M Lygizos; T L van der Merwe; S Bamber; Z Radebe; M Loveday; A P Moll; B Margot; U G Lalloo; G H Friedland; N R Gandhi
Journal:  Int J Tuberc Lung Dis       Date:  2012-06-05       Impact factor: 2.373

2.  Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in rural Bangladesh: lessons learnt.

Authors:  A Gumusboga; K J M Aung; L Rigouts; A Van Deun
Journal:  Public Health Action       Date:  2012-09-21

Review 3.  Transmission and Institutional Infection Control of Tuberculosis.

Authors:  Edward A Nardell
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

4.  Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data.

Authors:  Jonathan L Zelner; Megan B Murray; Mercedes C Becerra; Jerome Galea; Leonid Lecca; Roger Calderon; Rosa Yataco; Carmen Contreras; Zibiao Zhang; Justin Manjourides; Bryan T Grenfell; Ted Cohen
Journal:  J Infect Dis       Date:  2015-07-14       Impact factor: 5.226

5.  Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis.

Authors:  A S Dharmadhikari; M Mphahlele; K Venter; A Stoltz; R Mathebula; T Masotla; M van der Walt; M Pagano; P Jensen; E Nardell
Journal:  Int J Tuberc Lung Dis       Date:  2014-09       Impact factor: 2.373

6.  Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.

Authors:  Neel R Gandhi; Darren Weissman; Prashini Moodley; Melissa Ramathal; Inga Elson; Barry N Kreiswirth; Barun Mathema; Elena Shashkina; Richard Rothenberg; Anthony P Moll; Gerald Friedland; A Willem Sturm; N Sarita Shah
Journal:  J Infect Dis       Date:  2012-11-19       Impact factor: 5.226

Review 7.  Transmission of tuberculosis in resource-limited settings.

Authors:  Tejaswi Kompala; Sheela V Shenoi; Gerald Friedland
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

8.  A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa.

Authors:  J E Farley; C Tudor; M Mphahlele; K Franz; N A Perrin; S Dorman; M Van der Walt
Journal:  Int J Tuberc Lung Dis       Date:  2012-01       Impact factor: 2.373

9.  Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.

Authors:  N R Gandhi; J R Andrews; J C M Brust; R Montreuil; D Weissman; M Heo; A P Moll; G H Friedland; N S Shah
Journal:  Int J Tuberc Lung Dis       Date:  2012-01       Impact factor: 2.373

10.  Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.

Authors:  Maia Kipiani; Veriko Mirtskhulava; Nestani Tukvadze; Matthew Magee; Henry M Blumberg; Russell R Kempker
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.